Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA

Delayed Quote. Delayed  - 06/29 09:59:59 pm
11.11 USD   -0.63%
06/20 VANDA PHARMACEU : to Present at the JMP Securities Life Sciences Con..
06/15 VANDA PHARMACEU : FDA Grants Fanapt® Three Years of Marketing Exclus..
06/03 VANDA PHARMACEU : to Present at the Jefferies 2016 Healthcare Confer..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/23/2016 06/24/2016 06/27/2016 06/28/2016 06/29/2016 Date
11.35(c) 11.16(c) 10.7(c) 11.18(c) 11.11(c) Last
605 313 1 670 684 856 839 565 465 430 227 Volume
+1.16% -1.67% -4.12% +4.49% -0.63% Change
More quotes
Financials ($)
Sales 2016 148 M
EBIT 2016 -36,1 M
Net income 2016 -30,2 M
Debt 2016 -
Yield 2016 -
Sales 2017 168 M
EBIT 2017 -4,41 M
Net income 2017 -5,04 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 3,24x
Capi. / Sales2017 2,86x
Capitalization 479 M
More Financials
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.Its products portfolio includes HETLIOZ, Fanapt and Tradipitant, Trichostatin and AQW051.Vanda Pharmaceuticals was founded by... 
More about the company
Surperformance© ratings of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on VANDA PHARMACEUTICALS INC.
06/24 VANDA PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement (form 8-..
06/20 VANDA PHARMACEUTICALS : to Present at the JMP Securities Life Sciences Conferenc..
06/16 VANDA PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holders..
06/15 VANDA PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (fo..
06/15 VANDA PHARMACEUTICALS : FDA Grants Fanapt® Three Years of Marketing Exclusivity ..
06/09 VANDA PHARMACEUTICALS : to Present at the Jefferies 2016 Healthcare Conference
06/03 VANDA PHARMACEUTICALS : to Present at the Jefferies 2016 Healthcare Conference
06/02 VANDA PHARMACEUTICALS : Announces FDA Approval of the Fanapt® Supplemental New D..
05/27 Ulta Salon, FEI and Vanda Pharma rise while Terex slumps
05/26 VANDA PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (fo..
More news
Sector news : Bio Therapeutic Drugs
06/28DJGILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug
06/28DJGILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug
06/28DJGILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug
06/28 GILEAD SCIENCES : FDA approves first pill to treat all forms of hepatitis C
06/28 MAKING AN IMPACT AROUND THE GLOBE : Amgen Czech Republic Staff Give Back to Thei..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
06/15 Vanda nabs three-year market exclusivity for Fanapt for maintenance treatment..
05/27 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
05/26 FDA OKs expended use of Vanda's Fanapt for maintenance treatment of schizophr..
05/26 After Hours Gainers / Losers
05/23 Key FDA decisions coming this week
Advertisement
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Technical analysis trends VANDA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions